Title:
PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD SUGAR
Document Type and Number:
WIPO Patent Application WO/2021/057661
Kind Code:
A1
Abstract:
Disclosed is a pharmaceutical composition for lowering blood sugar, containing compound A (the structural formula thereof is as shown in formula I below) and/or a pharmaceutically acceptable salt thereof and metformin and/or a pharmaceutically acceptable salt thereof. The pharmaceutical composition can realize the synergistic effect of lowering blood sugar.
Inventors:
SUN JINGCHAO (CN)
JING XIAOLONG (CN)
JING XIAOLONG (CN)
Application Number:
PCT/CN2020/116525
Publication Date:
April 01, 2021
Filing Date:
September 21, 2020
Export Citation:
Assignee:
SHENZHEN SALUBRIS PHARM CO LTD (CN)
International Classes:
A61K31/155; A61K31/53; A61P3/10
Foreign References:
| CN102791701A | 2012-11-21 | |||
| CN109692164A | 2019-04-30 |
Other References:
YANG WENMING: "Treating Type2 Diabetes Mellitus using Saxagliptin, a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, Combined with Metformin and its Effect on Islet β-Cell Function", JOURNAL OF CLINICAL MEDICAL LITERATURE, vol. 5, no. 101, 17 December 2018 (2018-12-17), pages 97 - 98, XP009526889, ISSN: 2095-8242, DOI: 10.16281/j.cnki.jocml.2018.a1.058
Download PDF:
Previous Patent: ADJUSTABLE SAFETY FENCE
Next Patent: MAP LEVEL INDICATING METHOD, MAP LEVEL OBTAINING METHOD, AND RELATED PRODUCT
Next Patent: MAP LEVEL INDICATING METHOD, MAP LEVEL OBTAINING METHOD, AND RELATED PRODUCT